Umbilical Venous Versus Peripherally Inserted Central Catheters in Neonates: A Prospective Cohort Study of Complications, Catheter Survival, and CLABSI"

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

360 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-12-01

Study Completion Date

2028-12-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to prospectively compare umbilical venous catheters (UVCs) and peripherally inserted central catheters (PICCs) in neonates, focusing on complications, catheter survival, and central line-associated bloodstream infection (CLABSI) rates

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Interest of Peripheral Venous Catheter Insertion Using a Micro-guide in Neonatology

NCT04984967

Newborns Neonatology Intensive Care

RECRUITING NA

Umbilical Venous Catheter Insertion Depth in Neonates

NCT02939690

Central Venous Catheterization

COMPLETED NA

Less Pain in Neonates During Central Lines Insertion

NCT03647293

Central Venous Catheter Neonates Pain

COMPLETED NA

Feasibility and Safety of Ultrasound Guided Installation Central Subclavian Catheter Through Supraclavicular Way

NCT02809664

Heart Diseases Diseases, Metabolic

UNKNOWN

Ultrasound-Guided Peripheral Intravenous Access by Critical Nurses.

NCT02285712

Venous Catheterization

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Peripherally Inserted Central Catheter Umbilical Venous Catheter CLABSI - Central Line Associated Bloodstream Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

UVC group

UVC Group: Neonates who received umbilical venous catheters within the first 28 days of life.

umbilical venous catheters insertion

Intervention Type PROCEDURE

Neonates who received umbilical venous catheters within the first 28 days of life

PICC group

PICC Group: Neonates who received peripherally inserted central catheters within the first 28 days of life.

peripherally inserted central catheter insertion

Intervention Type PROCEDURE

Neonates who received peripherally inserted central catheters within the first 28 days of life.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

peripherally inserted central catheter insertion

Neonates who received peripherally inserted central catheters within the first 28 days of life.

Intervention Type PROCEDURE

umbilical venous catheters insertion

Neonates who received umbilical venous catheters within the first 28 days of life

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Neonates admitted to the neonatal intensive care unit (NICU) requiring central venous access.

* Infants in whom either an umbilical venous catheter (UVC) or a peripherally inserted central catheter (PICC) was inserted for clinical indications (Parenteral nutrition, administration of intravenous medications (e.g., antibiotics, inotropes, anticonvulsants, fluids) and blood sampling for frequent labs, especially in critically ill neonates).
* Catheter insertion performed within the first 28 days of life.

Exclusion Criteria

* Neonates with major congenital anomalies (e.g.abdominal wall defects) that may interfere with catheter placement or outcomes.
* Insertion site infection
* Infants with severe coagulopathy or bleeding disorders contraindicating central catheter insertion.
* Neonates who received both UVC and PICC simultaneously during the same admission.
* Cases with incomplete clinical records or missing follow-up data.

Minimum Eligible Age

0 Days

Maximum Eligible Age

28 Days

Eligible Sex

ALL

Accepts Healthy Volunteers

No